Tremelimumab
Collapse All+
Brand Name
+
Immune Checkpoint Inhibitor Class
+
Conventional Dosing
+
Extended-Interval Dosing
+
Fixed Dose or Capped Weight Based Dose
+
Treatment Duration
+
Preferred Dosing Frequency with Other Agents
+
Administration
+
Vial availability
+
Dose Relationship to efficacy and toxicity
+
Half-Life (5 x T1/2)
+